Mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D utility index.

OBJECTIVE This study aims to develop a function for mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General (FACT-G) scores to the EuroQoL Group's EQ-5D utility index and to test whether a single function is sufficient for the two language versions. METHODS A baseline survey of 558 cancer patients in Singapore using the FACT-G and EQ-5D was conducted (308 English and 250 Chinese questionnaires). Regression models were used to predict the EQ-5D utility index values based on the FACT-G scores and thus derive a mapping equation. Data from a follow-up survey of the patients were used to validate the results. RESULTS The FACT-G Social/Family scale was not associated with the EQ-5D utility index (P = 0.701). There was no interaction between language version and the predictors (each P > 0.1). An equation that maps the FACT-G Physical, Emotional, and Functional well-being scales to the EQ-5D utility index was derived. In the validation sample, the mean observed utility values was larger than the mapped by only 0.005 (95% confidence interval [CI]-0.006 to 0.016), but the mean absolute difference was 0.083 (95% CI 0.076 to 0.090). CONCLUSIONS At the group level, but not individual level, the equation developed can accurately map the English and Chinese versions of the FACT-G scores to the EQ-5D utility index.

[1]  N. Ikegami,et al.  Estimating an EQ-5D population value set: the case of Japan. , 2002, Health economics.

[2]  Vahram Ghushchyan,et al.  Mapping the EQ-5D Index from the SF-12: US General Population Preferences in a Nationally Representative Sample , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  David Graddol,et al.  The Future of Language , 2004, Science.

[4]  M. Suarez‐Almazor,et al.  Variation in the Estimation of Quality‐adjusted Life‐years by Different Preference‐based Instruments , 2003, Medical care.

[5]  D. Jolliffe,et al.  Censored least absolute deviations estimator: CLAD , 2001 .

[6]  Y. Cheung,et al.  The Singaporean English and Chinese versions of the EQ-5D achieved measurement equivalence in cancer patients. , 2009, Journal of clinical epidemiology.

[7]  Nan Luo,et al.  Do English and Chinese EQ-5D versions demonstrate measurement equivalence? an exploratory study , 2003, Health and quality of life outcomes.

[8]  Y. Cheung,et al.  The equivalence and difference between the English and Chinese versions of two major, cancer‐specific, health‐related quality‐of‐life questionnaires , 2004, Cancer.

[9]  L. Sharples,et al.  Performance status score: do patients and their oncologists agree? , 2003, British Journal of Cancer.

[10]  D. Brennan,et al.  Mapping oral health related quality of life to generic health state values , 2006, BMC Health Services Research.

[11]  J. Thumboo,et al.  Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. , 2003, Annals of the Academy of Medicine, Singapore.

[12]  C. Goh,et al.  Measuring quality of life in Chinese cancer patients: a new version of the Functional Living Index for Cancer (Chinese). , 2003, Annals of the Academy of Medicine, Singapore.

[13]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[14]  N. Sengupta,et al.  Mapping the SF-12 to the HUI3 and VAS in a Managed Care Population , 2004, Medical care.

[15]  M. Farrell,et al.  Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[16]  Jacek A Kopec,et al.  A comparative review of four preference-weighted measures of health-related quality of life. , 2003, Journal of clinical epidemiology.

[17]  Y. Cheung,et al.  Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A Simon Pickard,et al.  Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[20]  J. Thumboo,et al.  Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore , 2003, Quality of Life Research.

[21]  William F Lawrence,et al.  Predicting EuroQoL EQ-5D Preference Scores from the SF-12 Health Survey in a Nationally Representative Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.